UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
_________________
FORM
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported)
_________________
(Exact name of Registrant as specified in its charter)
_________________
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer |
(Address of principal executive offices)(Zip code)
(
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
_________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
The |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 - Submission of Matters to a Vote of Security Holders.
On June 7, 2023, OpGen, Inc. (the “Company”) held its 2023 annual meeting of stockholders (the “Annual Meeting”). At the Annual Meeting, the total number of shares represented in person or by proxy was 1,968,200 of the 5,514,449 shares of common stock outstanding and entitled to vote at the Annual Meeting as of the record date, April 12, 2023. The following matters were voted upon at the Annual Meeting:
1. Proposal 1 - Election of Directors. The election of the following named persons to serve as directors of the Company until the 2024 Annual Meeting of Stockholders or until their successors are elected and qualified. The votes cast were as follows:
Nominee |
For |
Vote Withheld |
Broker Non-Votes |
William E. Rhodes, III | 243,133 | 382,016 | 1,343,051 |
Mario Crovetto | 250,803 | 374,346 | 1,343,051 |
R. Donald Elsey | 247,334 | 377,815 | 1,343,051 |
Prabhavathi Fernandes, Ph.D. | 247,589 | 377,560 | 1,343,051 |
Oliver Schacht, Ph.D. | 222,773 | 402,376 | 1,343,051 |
Yvonne Schlaeppi | 293,577 | 331,572 | 1,343,051 |
2. Proposal 2 - Advisory Vote on Executive Compensation (Say on Pay). On a non-binding advisory basis, the Company's stockholders did not approve the compensation of the Company's named executive officers for 2022, based on the following voting results:
190,077 votes | FOR the proposal |
420,856 votes | AGAINST the proposal |
14,216 votes | ABSTAIN |
1,343,051 votes | Broker Non-Votes |
3. Proposal 3 - Ratification of Independent Accounting Firm. The Company’s stockholders ratified the appointment of UHY LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023, based on the following voting results:
1,347,326 votes | FOR the proposal |
337,259 votes | AGAINST the proposal |
283,615 votes | ABSTAIN |
0 votes | Broker Non-Votes |
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: June 7, 2023 | OpGen, Inc. | |||||
By: |
/s/ Oliver Schacht | |||||
Name: | Oliver Schacht | |||||
Title: | Chief Executive Officer |